1. Italy Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
EL.En. S.p.A.

EL.En. S.p.A.

ELN.MI
EL.En. S.p.A.IT flagItalian Stock Exchange
17.17
EUR
-0.31
- -
1.38BMarket Cap
EL.En. S.p.A.
ELN.MI
(Italian Stock Exchange)

Recent

price

17.17

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2.46
1.91
1.97
2.04
2.33
2.82
3.27
3.97
4.48
5.2
5.24
7.17
8.43
7.21
7.06
7.37
7.44
Revenue per Share
0.01
- -
0.3
0.08
0.21
0.19
0.52
0.2
0.22
0.34
0.26
0.57
0.69
0.6
0.64
0.54
0.42
Basic EPS, GAAP
0.05
-0.06
0.18
0.14
0.19
0.11
0.25
0.17
-0.19
0.21
0.36
0.79
-0.2
-0.01
1.04
0.88
- -
Free Cash Flow per Basic Share
- -
0.02
- -
0.05
0.04
0.07
0.08
0.12
0.11
0.11
- -
0.12
0.22
0.24
0.21
0.23
- -
Dividend per Share
0.3
0.31
0.48
0.51
0.7
0.58
1.02
0.69
0.91
1.21
1.14
1.69
2.15
2.38
2.67
2.8
- -
Book Value per Share
2.13
2.1
1.57
1.7
1.9
2.28
2.44
2.59
2.78
3.06
3.03
3.55
4.13
4.54
5.07
5.28
- -
Tangible Book Value per Share
77
72
77
77
77
77
77
77
77
77
78
80
80
80
80
80
80
Basic Weighted Avg Shares
190
137
151
157
180
218
253
306
346
401
408
571
674
576
566
591
596
Sales/Revenue/Turnover
2.86
2.44
3.44
5.05
7.38
9.04
9.79
8.67
7.15
8.76
6.05
10.38
11.18
12.81
12.69
12.22
12.26
Operating Margin (%)
6
3
3
3
3
3
4
4
4
7
8
9
10
9
12
10
7
Depreciation Expense
- -
- -
23
6
17
14
40
16
17
26
20
45
55
48
52
43
33
Net Income, GAAP
90.75
55.78
48.46
39.98
26.26
30.56
18.45
25.01
26.08
25.54
19.27
26.04
25.26
29.04
25.24
31.64
- -
Effective Tax Rate (%)
0.23
-0.2
15.34
3.86
9.18
6.6
15.99
5.1
4.85
6.49
4.96
7.95
8.18
8.37
9.12
7.35
5.59
Profit Margin (%)
136
129
80
77
103
95
141
154
155
162
173
212
240
267
467
345
- -
Working Capital
3
7
10
7
6
5
4
6
12
21
31
37
38
29
23
17
- -
LT Debt
172
175
124
134
151
180
193
204
219
241
241
288
343
375
411
427
- -
Total Equity
0.29
0.79
1.6
3.22
5.95
7.27
9.91
9.35
7.99
10.06
6.93
13.5
14.33
11.89
11.87
10.71
- -
Return on Invested Capital (%)
-0.25
-0.02
17.55
8.83
19.74
16.17
42.88
11.86
12.39
18.19
11.78
22.53
20.68
16.29
17.83
15.33
22.7
Return on Capital (%)
1.93
-1.18
78.52
15.94
35.23
29.01
65.12
23.61
27.26
31.96
22.25
40.63
36.03
26.66
25.54
19.82
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
21
- -
LT Borrowings
- -
6
- -
LT Finance Leases
- -
11
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
80
80
80
Market Capitalization
909
1,114
984

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
509
- -
Cash, Cash Equivalents & STI
- -
211
- -
Accounts Receivable, Net
- -
117
- -
Inventories
- -
157
- -
Total Current Liabilities
- -
164
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
21
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.21%
12.34%
4.06%
Free Cash Flow
-770.46%
-1,492.79%
-14.75%
Net Income, GAAP
28.43%
24.85%
-15.88%
Sales/Revenue/Turnover
11.4%
9.21%
4.42%
Total Cash Common Dividend
824.31%
1,656.87%
9.81%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
130
160
135
100
566
2025
141
144
137
169
591
2026
146
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.2
- -
0.24
- -
0.64
2025
0.2
- -
0.26
- -
0.54
2026
0.25
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.21
2025
- -
- -
- -
- -
0.23
2026
- -
- -
- -
- -
- -
Similar Companies
LexaGene Holdings Inc. (LXXGF)
Carlsmed, Inc. (CARL)
Neurotech International Limited (NTI.AX)
Advanced BioMedical Technologies Inc. (ABMT)
ImpediMed Limited (IPD.AX)
RxSight, Inc. (RXST)
Business
El.En. S.p.A. engages in the design, production, and marketing of laser sources and laser equipment for medical, aesthetic, industrial, and cultural heritage applications. The company’s core products include medical laser devices used in dermatology, surgery, aesthetics, physiotherapy, dentistry, urology, and gynecology; industrial laser systems for cutting, marking, welding, and engraving metals, plastics, wood, glass, leather, paper, cardboard, and fabrics; and laser technologies for the conservative restoration of artworks. It also offers after-sales assistance and develops advanced laser systems such as sealed-off and self-refilling RF CO₂ lasers, fiber galvo scanners, and OEM laser solutions. El.En. operates internationally, with a presence across Europe, America, and Asia, and maintains a broad portfolio designed to enhance efficiency, productivity, and performance in various industries. Founded in 1981 and headquartered in Calenzano, Italy, El.En. leads an international group of high-tech companies in optoelectronics. Recent major changes include robust growth in the medical sector marked by increased sales in high-margin categories like anti-aging treatments and surgical laser systems, especially in urology. The company has been actively expanding its capacity in optical fibers to meet future demand. Although the industrial division faced challenges with delayed revenues and weaker performance, ongoing strategic efforts focus on bolt-on acquisitions in both medical and industrial fields primarily within Europe and globally. Additionally, El.En. has divested a majority stake in one of its subsidiaries to strengthen cash flow and reinforce financial positioning. The company continues to prioritize research and development for continuous innovation, aiming to introduce new laser applications and technologies. It maintains a strong commitment to social responsibility, customer support, and environmental sustainability. El.En. distributes its products globally with a comprehensive network and serves a wide range of professional customers, including medical practitioners, industrial manufacturers, and cultural heritage conservation specialists. Its solutions encompass advanced medical laser systems, high-power industrial lasers, and specialized equipment for art restoration to improve quality of life and operational productivity worldwide.

Company News

APIChatGPT

  • headlinesoftoday.com

    After the Great Success Achieved in the United States and Canada, DEKA Launches Three Extraordinary Laser and Microwave Platforms at the World Congress of Dermatology in Singapore